Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review

  • ID: 4225267
  • SWOT Analysis
  • 52 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Danaher Corp
  • DNA Therapeutics SA
  • Merck KGaA
  • Qiagen Marseille SA
  • MORE
Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and lab technologies. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, pipette tips, fermentors, moisture analyzers, filters, bioreactors, shakers, virus purification kits, and centrifuges, among others. SSB also offers instrument services, spare parts and consumables, training and information on disposal. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells its products through direct sales force in the Americas, Europe, the Middle East, Africa and Asia-Pacific. SSB is headquartered in Aubagne, France.

Sartorius Stedim Biotech SA Key Recent Developments

Feb 21, 2018 Sartorius Looks Ahead to Sustained, Highly Profitable Growth - Sales Revenue to Rise to around 4 Billion Euros by 2025
Jan 31, 2018 Sartorius Grows Significantly Again in Sales Revenue and Earnings In 2017 - Positive Outlook For 2018
Jan 10, 2018 Quad Technologies Partners With Sartorius Stedim Biotech On CD3/CD28 T Cell Activation Product
Jan 04, 2018 Abzena selects Sartorius Stedim Biotech to equip their U.S. based development and manufacturing sites in San Diego and Bristol

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Danaher Corp
  • DNA Therapeutics SA
  • Merck KGaA
  • Qiagen Marseille SA
  • MORE
Section 1 - About the Company
  • Sartorius Stedim Biotech SA - Key Facts
  • Sartorius Stedim Biotech SA - Key Employees
  • Sartorius Stedim Biotech SA - Key Employee Biographies
  • Sartorius Stedim Biotech SA - Major Products and Services
  • Sartorius Stedim Biotech SA - History
  • Sartorius Stedim Biotech SA - Company Statement
  • Sartorius Stedim Biotech SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sartorius Stedim Biotech SA - Business Description
  • Sartorius Stedim Biotech SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Sartorius Stedim Biotech SA - Strengths
  • Sartorius Stedim Biotech SA - Weaknesses
  • Sartorius Stedim Biotech SA - Opportunities
  • Sartorius Stedim Biotech SA - Threats
  • Sartorius Stedim Biotech SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Sartorius Stedim Biotech SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 21, 2018: Sartorius Looks Ahead to Sustained, Highly Profitable Growth - Sales Revenue to Rise to around 4 Billion Euros by 2025
  • Jan 31, 2018: Sartorius Grows Significantly Again in Sales Revenue and Earnings In 2017 - Positive Outlook For 2018
  • Dec 07, 2017: Sartorius Stedim Biotech launches new versions of data analytics software solutions
  • Sep 18, 2017: Sartorius Stedim Biotech: Lothar Kappich Appointed to the Board of Directors
  • Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise
  • Jun 26, 2017: Advanced software solution ensures superior manufacturing quality and enables effective decision-making
  • Jun 26, 2017: Active Dashboard 2 Allows Easy Access to Process Performance Data
  • Jun 23, 2017: Sartorius Stedim Biotech Introduces Sartobind Cassettes
  • Apr 28, 2017: Sartorius Stedim Biotech Introduces New BIOSTAT STR Bioreactor Range
  • Apr 24, 2017: First-quarter figures: Sartorius Stedim Biotech off to a good start in 2017
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Sartorius Stedim Biotech SA, Key Facts
  • Sartorius Stedim Biotech SA, Key Employees
  • Sartorius Stedim Biotech SA, Key Employee Biographies
  • Sartorius Stedim Biotech SA, Major Products and Services
  • Sartorius Stedim Biotech SA, History
  • Sartorius Stedim Biotech SA, Subsidiaries
  • Sartorius Stedim Biotech SA, Key Competitors
  • Sartorius Stedim Biotech SA, Ratios based on current share price
  • Sartorius Stedim Biotech SA, Annual Ratios
  • Sartorius Stedim Biotech SA, Annual Ratios
  • Sartorius Stedim Biotech SA, Annual Ratios
  • Sartorius Stedim Biotech SA, Interim Ratios
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Sartorius Stedim Biotech SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sartorius Stedim Biotech SA, Performance Chart (2012 - 2016)
  • Sartorius Stedim Biotech SA, Ratio Charts
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Sartorius Stedim Biotech SA, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Thermo Fisher Scientific Inc
  • Qiagen Marseille SA
  • Merck KGaA
  • General Electric Capital Corporation
  • DNA Therapeutics SA
  • Danaher Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll